Addressing Unmet Medical Needs
TRANSMAB® TECHNOLOGY
TARGET
INDICATION
DISCOVERY
PRE-CLINICAL
EARLY CLINICAL
LATE CLINICAL
PARTNERSHIP
PD-L1
Alzheimer's
Undisclosed
Tau
Neurodegenerative
Neuro-Oncology
Internal
